Eyenovia, a public biotech company, has announced a significant investment in cryptocurrency HYPE, marking its entry into digital assets.
Eyenovia's Investment in HYPE
Eyenovia, listed on Nasdaq, announced a $50 million investment in HYPE tokens, becoming the first publicly traded U.S. company to hold HYPE tokens and become a validator on the Hyperliquid network.
About Hyperliquid and the HYPE Token
Hyperliquid is a high-speed Layer 1 blockchain platform designed for perpetual trading, offering sub-second transaction finality and processing up to 100,000 orders per second. The HYPE token, ranked 12th by market capitalization, reached an all-time high of $45.57 in mid-June 2025.
Market Impact and Eyenovia's Future
Eyenovia's investment could encourage other public companies to explore crypto investments, potentially increasing demand for Hyperliquid tokens and solidifying the network’s market position. Eyenovia also plans to rebrand to Hyperion DeFi and change its ticker symbol to HYPD, indicating a strategic shift towards blockchain-based financial technologies.
Eyenovia's investment in HYPE tokens marks a significant step towards integrating traditional business with cryptocurrencies, opening new horizons for public companies.